BioSpace News Archive

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), today announced that LineaRx, the Company’s majority-owned biotherapeutics subsidiary, has for the first time successfully administered and expressed a linearDNA-LNP construct in mice via routine intramuscular (IM) injection without the concurrent use of electroporation (EP) that utilizes electrical pulses to deliver DNA to target cells.

According to the report, the global PCR & real-time PCR molecular market was valued over US$ 4.1 Bn in 2021.

The demand for high quality patient care is surging in the U.S. healthcare landscape.

Specialty cancer diagnostics company Precipio, Inc., welcomes Toni-Ann Mills as the Company’s Senior Director for Learning & Development.

Panacell Biotech Co., Ltd. said that NK cells, exosomes, and brown adipose-derived stem cells are effective to treat patients with long COVID conditions, or post COVID-19 conditions, as well as those with terminal illness.

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, may have developed a novel blood test that can be used to detect early-onset colorectal cancer, which has been on the rise in younger adults in recent years.

According to Nova one advisor’s latest research report on the The global AI in Medical Imaging market gathered revenue around USD 20.18 billion by the end of 2030 and is estimated to expand at a modest CAGR of 36.9% during the prediction period 2022 to 2030.

The global Artificial Intelligence (Ai) In Medical Diagnostics market for the historical period of 2021 and the forecast period from 2020 to 2030, the global Artificial Intelligence (Ai) In Medical Diagnostics market was valued at US$ 2.4 million in 2021 and is projected to cross US$ 10.9 Bn by 2030, expanding at a CAGR of 37.2% from 2022 to 2030.

According to Nova one advisor’s latest research report on the global Artificial Intelligence In Diagnostics market size was estimated at USD 580.3 billion in 2021 and is expected to surpass around USD 5.9 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 26.7% during the forecast period 2022 to 2030.

Latest Study on “Artificial Intelligence In Drug Discovery Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.